On behalf of the CVC and the Beyond 2018 (B2K18) educational program, we are pleased to share a Canadian Cardiovascular Society-accredited webinar series initiative that is being provided as an extension to the B2K18 symposium (held annually during the Canadian Cardiovascular Congress, most recently October 22, 2018).
Webinar 1 – Lipid Modifying Treament Post-ACS
The first webinar in this series took place December 4, 2018 and covered the topic of Lipid Modifying Treament Post-ACS. This webinar featured the symposium presentation by Dr. Gabriel Steg, along with a live interactive case study by Dr. Michael Heffernan, and an ODYSSEY OUTCOMES trial update (including data just presented at the American Heart Association Scientific Sessions) by Dr. Shaun Goodman. A recording of the webinar will be available soon.